Clinical Trials in San Francisco

Showing 3841-3860 of 6,211 trials

Yoga During Chemotherapy Study

NCT02442635

This proposal aims to expand non-pharmacologic options for the control of symptoms during chemotherapy using yoga practices. It is particularly focused on sleep disturbance with a secondary focus on fatigue.

CancerSleep DisturbanceFatigue

University of California, San Francisco73 participantsStarted May 2015

San Francisco, California, United States

COMPLETEDNA< 1 mile

Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study

NCT01766674

This is a randomized, controlled trial among 100 total males and females with hyperkyphosis, aged 60 years and older, to determine the effects of an exercise intervention that includes high intensity spinal muscle strengthening exercises compared to a usual care waitlist group.

Kyphosis

University of California, San Francisco112 participantsStarted Feb 2013

San Francisco, California, United States

COMPLETEDPhase 1< 1 mile

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

NCT01545947

The main purpose of this first study combining an investigational dual mTOR inhibitor, CC-223, with other agents (erlotinib or the investigational agent, oral azacitidine) is to establish a maximum tolerated dose level for each combination in order to evaluate their effects in future clinical trials for advanced non-small cell lung cancer.

Carcinoma, Non-Small-Cell LungNon-Small Cell Lung Cancer

Celgene76 participantsStarted May 2012

Los Angeles, California, United States • San Francisco, California, United States • New York, New York, United States +6 more locations

Yoga During Chemotherapy Study

Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

Find Trials by Condition in San Francisco

World-wide Randomized Antibiotic Envelope Infection Prevention Trial

SPRINT - Randomized Trial of Tibial Fracture Fixation

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis

Intrafetal Digoxin as an Adjuvant for Dilation and Evacuation at 20 to 24 Weeks' Gestation

A 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment Intensification

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients

Evaluation of a Non-invasive Brain Compliance Measurement Device

Comparison Bile Duct Brushings, Cholangioscopy-Directed Biopsies and Pediatric Forceps Biopsies in Biliary Strictures

A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (CTCL)

An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia

Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects

The Modifying the Impact of ICU-Associated Neurological Dysfunction-USA (MIND-USA) Study